Other Income/Expenses (Net)

-$1.39B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported-$1.39Bperiod endingJun 30, 2026

AZN TTM Other Income/Expenses (Net) (-$1.02B → -$1.39B)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

AZN other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	217,990,041
Mar 31, 2001	209,049,731
Dec 31, 2000	185,207,310
Sep 30, 2000	-755,763,225
Jun 30, 2000	-734,641,179
Mar 31, 2000	-710,700,869
Dec 31, 1999	-5,273,148,052
Sep 30, 1999	832,152,120
Jun 30, 1999	-1,529,047,880
Mar 31, 1999	-1,221,047,880
Dec 31, 1998	882,952,120
Sep 30, 1998	82,690,173
Jun 30, 1998	313,490,173
Mar 31, 1998	-2,314,509,827
Dec 31, 1997	-2,181,009,827
Sep 30, 1997	-3,908,642,638
Jun 30, 1997	-4,122,842,638
Mar 31, 1997	-4,117,342,638
Dec 31, 1996	-4,111,842,638
Sep 30, 1996	-2,746,891,669
Jun 30, 1996	-2,368,291,669
Mar 31, 1996	-70,591,669
Dec 31, 1995	190,808,331
Sep 30, 1995	51,622,867
Jun 30, 1995	233,822,867
Mar 31, 1995	-1,622,177,133
Dec 31, 1994	-1,441,877,133
Sep 30, 1994	-1,411,570,464
Jun 30, 1994	-1,195,770,464
Mar 31, 1994	-1,107,470,464
Dec 31, 1993	-1,019,170,464